Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 7

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 7
---
 immediately after consummation of the Business Combination. See the section entitled “ Special Meeting of FutureTech — Redemption Rights” in the accompanying proxy statement/prospectus for a detailed description of the procedures to be followed if you wish to redeem your public shares for cash.

Notwithstanding the foregoing, a public stockholder, together with any affiliate of such public stockholder or any other person with whom such public stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its public shares with respect to more than an aggregate of 15% of the public shares. Accordingly, if a public stockholder, alone or acting in concert or as a group, seeks to redeem more than 15% of the public shares, then any such shares in excess of that 15% limit would not be redeemed for cash.

The Sponsor and each of FutureTech’s executive officers and directors (including certain former executive officers and directors, as the context so requires) (the “Sponsor Persons”) have agreed to, among other things, vote in favor of the Merger Agreement and the transactions contemplated thereby, and to waive their redemption rights in connection with the consummation of the Business Combination with respect to any shares of FutureTech Common Stock held by them. Such persons agreed to waive their redemption rights in order to induce FutureTech and FutureTech’s underwriter to enter into the underwriting agreement entered into in connection with the initial public offering. As of the date of the accompanying proxy statement/prospectus, the Sponsor Persons collectively own 79.1% of the issued and outstanding shares of FutureTech Common Stock.

The Merger Agreement is also subject to the satisfaction or waiver of certain other closing conditions as described in the accompanying proxy statement/prospectus. There can be no assurance that the parties to the Merger Agreement would waive any such provision of the Merger Agreement.

Nasdaq IM-5101-2 requires
that FutureTech, a special purpose acquisition company, complete one or more business combinations within 36 months of the effectiveness
of its initial public offering registration statement, which, in the case of FutureTech, would be February 14, 2025. FutureTech’s
Combination Period ending on August 18, 2025 contravenes Nasdaq IM-5101-2 and, as a result, may lead Nasdaq to suspend trading FutureTech